- Home
- KROS vs NBTB Comparison
KROS vs NBTB Comparison
Compare KROS & NBTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- NBTB
- Stock Information
- Founded
- KROS 2015
- NBTB 1856
- Country
- KROS United States
- NBTB United States
- Employees
- KROS N/A
- NBTB N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- NBTB Major Banks
- Sector
- KROS Health Care
- NBTB Finance
- Exchange
- KROS Nasdaq
- NBTB Nasdaq
- Market Cap
- KROS 1.8B
- NBTB 2.0B
- IPO Year
- KROS 2020
- NBTB N/A
- Fundamental
- Price
- KROS $56.62
- NBTB $49.26
- Analyst Decision
- KROS Strong Buy
- NBTB Buy
- Analyst Count
- KROS 8
- NBTB 5
- Target Price
- KROS $91.43
- NBTB $42.60
- AVG Volume (30 Days)
- KROS 383.1K
- NBTB 216.5K
- Earning Date
- KROS 11-06-2024
- NBTB 10-28-2024
- Dividend Yield
- KROS N/A
- NBTB 2.76%
- EPS Growth
- KROS N/A
- NBTB 0.14
- EPS
- KROS N/A
- NBTB 2.85
- Revenue
- KROS $651,000.00
- NBTB $538,802,000.00
- Revenue This Year
- KROS $1,232.45
- NBTB N/A
- Revenue Next Year
- KROS $126.39
- NBTB $16.98
- P/E Ratio
- KROS N/A
- NBTB $17.27
- Revenue Growth
- KROS 8037.50
- NBTB 10.23
- 52 Week Low
- KROS $27.31
- NBTB $32.79
- 52 Week High
- KROS $73.00
- NBTB $51.93
- Technical
- Relative Strength Index (RSI)
- KROS 38.94
- NBTB 59.90
- Support Level
- KROS $65.54
- NBTB $50.03
- Resistance Level
- KROS $70.26
- NBTB $51.93
- Average True Range (ATR)
- KROS 3.17
- NBTB 1.56
- MACD
- KROS -0.64
- NBTB 0.38
- Stochastic Oscillator
- KROS 9.07
- NBTB 68.33
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About NBTB NBT Bancorp Inc.
NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. NBT Bank is a full-service community bank offering a full range of retail and commercial banking products and trust and investment services. Loan products include consumer, home equity, mortgage, business banking, and commercial loans. Nearly half of its loan portfolio is in commercial loans. The bank serves individuals, corporations, and municipalities, and operates scores of locations throughout New York, Pennsylvania, Vermont, Massachusetts, New Hampshire, and Maine.